RIABNI™ (rituximab-arrx) is indicated for the treatment of adult patients with: Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent...Read more Indications Prescribing Information Medication Guide Visit AmgenBiosimilars.com New...
Riabni(rituximab-arrx)治疗复发或难治性、低级别或滤泡性、CD20阳性、B细胞非霍奇金淋巴瘤效果怎么样? 利妥昔单抗治疗复发、难治性CD20+非霍奇金淋巴瘤的安全性和有效性已在3项单臂研究中得到证实,纳入了296名患者。 研究1 研究1纳入166名接受375mg/平方米的复发或难治性、低级别或滤泡性B细胞非霍奇金淋巴瘤...
12利妥昔单抗生物仿制药产品(利妥昔单抗-arrx、利妥昔单抗-abb、利妥昔单抗-pvvr)的标签中不包括利妥昔单抗的这些适应症。利妥昔单抗HYCELA(利妥昔单抗和透明质酸酶人体注射液,用于皮下注射)组合产品不适用于非恶性疾病的治疗。 目前利妥昔单抗已经在国内上市,并且已经纳入医保。国内利妥昔单抗价格大约在2500~...
药品名称 ABP 798; ABP798; Riabni; rituximab-arrx 药品类别 生物类似药; 生物; 抗体 靶点 cluster of differentiation 20 (CD20) 作用机制 anti-CD20单抗 药品简介 -- 研发机构 Watson Pharmaceutical (AbbVie) ;Amgen 最高研发阶段 全球: 批准上市 中国: III期临床 美国: 批准上市 审评审批类型 ...
Riabni (rituximab-arrx) - Amgen Inc. Formulation typeStrength Single-Dose Vial 100 mg/10 mL (10 mg/mL) Single-Dose Vial 500 mg/50 mL (10 mg/mL) View Riabni information in detail. Ruxience (rituximab-pvvr) - Pfizer Ireland Pharmaceuticals Formulation typeStrength Single-Dose Vial 100 ...
FDA Approved Drug Products: RIABNI (rituximab-arrx) injection, for intravenous use [Link] FDA Approved Drug Products: RITUXAN HYCELA (rituximab and hyaluronidase human) injection, for subcutaneous use [Link] Genentech: RITUXAN (rituximab) SDS [Link] FDA Approved Drug Products: RUXIENCE® (...
药物别名 Rituximab;rituximab-abbs;rituximab-arrx;rituximab-pvvr 治疗类别 Amino Acids, Peptides, and Proteins;Antibodies;Antibodies, Monoclonal;Antibodies, Monoclonal, Murine-Derived;Antineoplastic Agents;Biologics for Rheumatoid Arthritis Treatment;Blood Proteins;CD20-directed Antibody Interactions;CD20-directed...
Common Generic Name(s): rituximab, rituximab-arrx, rituximab/hyaluronidase, rituximab-pvvr, rituximab-abbs Pronunciation: ri-TUX-i-mab Drug Classes: anti-CD20 monoclonal antibody Availability: prescription only; generic available for some forms How is it used? liquid that is injected into a blood...
Rituximab-arrx是一种针对CD20抗原的基因工程嵌合鼠/人单克隆IgG1kappa抗体。 Riabni(rituximab-arrx)注射液是一种无菌、不含防腐剂、透明至微乳白色、无色至微黄色溶液,用于静脉内输注。 Riabni的作用机制 利妥昔单抗产品靶向在前B淋巴细胞和成熟B淋巴细胞表面表达的CD20抗原。与CD20结合后,利妥昔单抗产物介导B...
The FDA has approved rituximab-arrx (Riabni; Amgen), abiosimilarto the reference rituximab (Rituxan), in combination with methotrexate for patients with moderate to severely active rheumatoid arthritis (RA) who have shown an inadequate response to 1 or more tumor necrosis factor (TNF) antagon...